BioLife Solutions, Inc. (BLFS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -491K | 4.92M | 6.1M | 7.37M | 1.73M | 1.65M | 4.8M | 6.46M | -4.47M | 2.31M | -4.38M | -7.72M |
| Operating CF Margin % | -1.79% | 26.17% | 21.75% | 28.98% | 7.21% | -48.04% | 15.71% | 32.76% | -24.28% | 13.29% | -18.58% | -19.54% |
| Operating CF Growth % | -128.43% | 198.84% | 27.11% | 14.07% | 138.59% | -28.82% | 209.66% | 183.69% | -65.01% | -70.58% | -392.71% | 22.17% |
| Net Income | 1.19M | 11.07M | 621K | -15.84M | -448K | 12.46M | -15.28M | -20.72M | -10.22M | -13.38M | -29.13M | -10.2M |
| Depreciation & Amortization | 699K | 586K | 1.33M | 1.38M | 1.38M | 1.7M | 2.32M | 2.36M | 2.28M | 2.38M | 3.28M | 3.46M |
| Stock-Based Compensation | 4.81M | 7.08M | 5.9M | 5.86M | 4.15M | 10.69M | 5.33M | 8.72M | 6.18M | 8.33M | 9.12M | 6.86M |
| Deferred Taxes | 9K | 0 | 14K | 45K | 6K | 24K | -93K | 0 | 5K | -98K | 23K | -8.99M |
| Other Non-Cash Items | -310K | -11.57M | 1.22M | 15.84M | 394K | -24.36M | 13.12M | 12.86M | -81K | -160K | 14.23M | 2.48M |
| Working Capital Changes | -6.88M | -2.24M | -2.99M | 85K | -3.76M | 1.12M | -594K | 3.23M | -2.64M | 5.24M | -1.9M | -1.32M |
| Change in Receivables | -5.1M | 1.94M | -782K | -893K | 1K | -1.23M | 208K | -1.94M | 65K | 5.91M | 2.35M | 3.48M |
| Change in Inventory | -2.68M | -2.33M | -197K | -187K | 1.45M | -1.34M | 317K | 1.76M | 42K | -102K | -4.18M | 2.15M |
| Change in Payables | 2.21M | -952K | -679K | 373K | -828K | 1.17M | -373K | 1.19M | -1.96M | -5.04M | 1.3M | -4.84M |
| Cash from Investing | -1.83M | 1.14M | -5.97M | -39.53M | -27.18M | 73.64M | -1.68M | -13.44M | -221K | 3.96M | 1.66M | 9.29M |
| Capital Expenditures | -167K | -4.26M | -3.3M | -1.74M | -175K | -762K | -1.11M | -995K | -356K | -981K | -1.5M | -609K |
| CapEx % of Revenue | 0.61% | 22.67% | 11.76% | 6.86% | 0.73% | -22.25% | 3.64% | 5.05% | 1.93% | 5.64% | 6.35% | 1.54% |
| Acquisitions | 0 | 33.74M | 0 | 0 | 0 | 73.43M | 13.04M | -13.04M | 973K | 0 | 1.12M | 1.33M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 122K | -10.32M | -373K | -10.08M | -250K | -300K | -13.07M | -1.13M | -973K | 0 | -2.02M | -2.88M |
| Cash from Financing | -7.89M | -2.5M | -2.56M | -2.88M | -2.99M | -4.09M | -1.04M | -704K | -952K | 9.84M | 608K | 704K |
| Debt Issued (Net) | -2.5M | -2.5M | -2.5M | -2.5M | -2.5M | -3.43M | -2.71M | -227K | -241K | 185K | -427K | -129K |
| Equity Issued (Net) | 190K | 0 | 0 | 18K | 0 | 65K | 46K | 91K | 0 | 10.38M | 64K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -5.58M | 4K | -58K | -396K | -492K | -725K | 1.63M | -568K | -711K | -725K | 971K | 833K |
| Net Change in Cash | -10.22M | 3.56M | -2.42M | -35.04M | -28.44M | 71.22M | 2.12M | -7.68M | -5.71M | 16.17M | -2.17M | -16.84M |
| Free Cash Flow | -658K | -9.56M | 2.8M | 5.63M | 1.55M | 583K | 3.69M | 5.46M | -4.83M | 1.33M | -5.88M | -8.33M |
| FCF Margin % | -2.39% | -50.91% | 9.98% | 22.13% | 6.48% | -17.03% | 12.06% | 27.71% | -26.21% | 7.65% | -24.92% | -21.08% |
| FCF Growth % | -142.4% | -1740.31% | -24.02% | 2.95% | 132.13% | -56.17% | 162.77% | 165.62% | 19.58% | -60.97% | -518.42% | 30.33% |
| FCF per Share | -0.01 | -0.20 | 0.06 | 0.12 | 0.03 | 0.01 | 0.08 | 0.12 | -0.11 | 0.03 | -0.13 | -0.19 |
| FCF Conversion (FCF/Net Income) | -0.41x | 1.39x | 9.83x | -0.47x | -3.85x | 0.13x | -2.82x | -0.31x | 0.44x | -0.17x | 0.15x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 265K | 372K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |